General Information of Drug (ID: DMIDJBY)

Drug Name
V184
Indication
Disease Entry ICD 11 Status REF
Chikungunya virus infection 1D40 Phase 2 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DI5V7K

References

1 ClinicalTrials.gov (NCT03807843) Phase 2 Study of a Live Attenuated Measles Virus-Vectored Chikungunya Vaccine in Previously Exposed Adults. U.S.National Institutes of Health.